PT-141 (Bremelanotide) – Research Peptide

PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide derived from α-melanocyte-stimulating hormone (α-MSH). It is a potent agonist of melanocortin receptors, primarily MC3R and MC4R, and is widely used in experimental research focused on sexual behavior, neuroendocrine signaling, motivation, mood, and central nervous system (CNS) pathways.

Unlike PDE-5 inhibitors or peripheral vasodilators, PT-141 acts centrally, modulating neural circuits in the hypothalamus and limbic system rather than acting directly on vascular smooth muscle.

Specifications

• Synonyms: PT-141, Bremelanotide

• Peptide class: Melanocortin receptor agonist

• Primary receptors: MC3R, MC4R

• Molecular formula: C₅₀H₆₈N₁₄O₁₀

• Molecular weight: ~1,025.2 g/mol

• Structure: Cyclic peptide (α-MSH analog)

• Research domains: Neuroendocrinology, sexual behavior, motivation, CNS signaling, melanocortin biology

Mechanism of Action – Central Melanocortin Signaling

PT-141 activates melanocortin receptors in the brain, particularly MC4R, leading to downstream signaling through:

• cAMP/PKA pathways

• Hypothalamic dopamine modulation

• Limbic system activation

• Reduced inhibitory serotonergic tone

This results in enhanced sexual motivation and arousal independent of nitric-oxide–mediated vasodilation.

Key mechanistic features:

• Acts centrally, not peripherally

• Does not require sexual stimulation to activate pathways

• Bypasses vascular mechanisms

• Minimal effect on testosterone or estrogen levels

PT-141 and Sexual Behavior Research

Male Models

Experimental and clinical research demonstrates that PT-141:

• Enhances sexual desire and initiation behavior

• Improves erectile response via central pathways

• Activates hypothalamic nuclei involved in sexual motivation

Female Models

PT-141 is extensively studied for:

• Female sexual arousal disorder (FSAD) models

• Hypoactive sexual desire pathways

• Central arousal independent of genital blood flow

Functional imaging studies show activation of the hypothalamus and limbic structures following PT-141 exposure.

Neuroendocrine and CNS Effects

PT-141 modulates several CNS systems:

Dopaminergic Pathways

• Enhances dopamine signaling linked to motivation and reward

• Influences mesolimbic circuits

Serotonergic Modulation

• Reduces inhibitory serotonergic tone associated with sexual suppression

Stress and Mood Signaling

• MC4R involvement suggests overlap with stress-response and mood regulation networks

These properties make PT-141 useful for studying motivation, reward processing, and neurobehavioral integration.

PT-141 vs Peripheral Erectile Pathways

This distinction explains PT-141’s use as a central neurobehavioral research compound rather than a vascular agent.

Other Experimental Applications

Researchers also use PT-141 in studies involving:

• Melanocortin receptor mapping

• Appetite and energy-balance signaling (MC3R/MC4R overlap)

• CNS receptor desensitization and tolerance models

• Sexual behavior in stress or SSRI-exposed models

Research Use Only – Important Notice

This PT-141 product is supplied exclusively for laboratory research purposes.

• Not for human or veterinary use

• Not for diagnostic, therapeutic, or cosmetic applications

• Intended only for in vitro studies or controlled experimental animal models

• All descriptions summarize preclinical and mechanistic research and do not constitute medical claims

References

1. King SH et al. Central melanocortin receptors and sexual behavior. J Neurosci.
   https://pubmed.ncbi.nlm.nih.gov/15659638/

2. Wessells H et al. Melanocortin receptor agonists in erectile and sexual function research. J Urol.
   https://pubmed.ncbi.nlm.nih.gov/14767286/

3. Clayton AH et al. Bremelanotide: a centrally acting melanocortin receptor agonist. J Sex Med.
   https://pubmed.ncbi.nlm.nih.gov/19090890/

4. Pfaus JG et al. Dopamine and sexual motivation: central pathways. Behav Brain Res.
   https://pubmed.ncbi.nlm.nih.gov/17574679/

5. Hadley ME, Haskell-Luevano C. The proopiomelanocortin system and melanocortin receptors. Endocr Rev.
   https://pubmed.ncbi.nlm.nih.gov/16174816/

6. Safarinejad MR. Neuroendocrine control of sexual function. Urol J.
   https://pubmed.ncbi.nlm.nih.gov/20311445/